News Feed

2604, 2019

Stealth BioTherapeutics Completes Enrollment of Pivotal Study in Primary Mitochondrial Myopathy

April 26th, 2019|0 Comments

Top-line data expected by end of 2019 NEWS PROVIDED BY Stealth BioTherapeutics  Apr 25, 2019, 16:15 ET BOSTON, April 25, 2019 /PRNewswire/ -- Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of [...]

1012, 2018

Stealth BioTherapeutics Granted Fast Track Designation for Elamipretide for the Treatment of Dry Age-Related Macular Degeneration with Geographic Atrophy

December 10th, 2018|0 Comments

BOSTON, Dec. 10, 2018 /PRNewswire/ -- Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its lead [...]

3006, 2018

UMDF Honors Volunteers with Top National Awards

June 30th, 2018|0 Comments

(Nashville, TN)   At its annual international mitochondrial disease symposium, Mitochondrial Medicine 2018, the United Mitochondrial Disease Foundation recognized four individuals for their efforts to spread awareness about mitochondrial disease. During the June 29, 2018 [...]

903, 2018

Intravenous Arginine Benefits Children after Acute Metabolic Strokes — CHOP Researchers Find Notable Responses, No Adverse Events in Children with Mitochondrial Disease

March 9th, 2018|0 Comments

FOR IMMEDIATE RELEASE Friday, March 9, 2018 John Ascenzi Children’s Hospital of Philadelphia (267) 426-6055 Ascenzi@email.chop.edu Intravenous Arginine Benefits Children after Acute Metabolic Strokes --CHOP Researchers Find Notable Responses, No Adverse Events in Children [...]

1801, 2018

Meeting report from the Mitochondrial Medicine Southeast Regional Symposium – understanding mitochondrial disease and mitochondrial dysfunction: Opportunities and impacts in the clinic and laboratory.

January 18th, 2018|0 Comments

This meeting report is from the 2017 Mitochondrial Medicine Southeast Regional Symposium, that UMDF conducted with the Foundation for Mitochondrial Medicine.  It was published in the Journal of Translational Science of Rare Diseases.  [...]

301, 2018

Mito Town Hall Meeting on January 5th

January 3rd, 2018|0 Comments

Friday, January 5th, join the entire community at 12PM EST.  Representatives from mitochondrial disease organizations and institutions from around the world talk about what's ahead for the community in 2018!  Join us at 1-866-414-2828, participant [...]

210, 2017

Stealth BioTherapeutics Granted Orphan Drug Designation of Elamipretide for Treatment of Patients with Primary Mitochondrial Myopathy

October 2nd, 2017|0 Comments

BOSTON, October 2, 2017 /PRNewswire/ -- Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing therapeutics to treat mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has [...]

408, 2017

UMDF Grant Recipients Awarded

August 4th, 2017|0 Comments

FOR IMMEDIATE RELEASE August 4, 2017 Contact: Clifford Gorski Director of Communications 412.793.8077 cliff@umdf.org UMDF RESEARCH GRANT RECIPIENT AWARDS FOUNDATION MAKES $625,000 SCIENTIFIC INVESTMENT TOWARDS TREATMENTS AND CURES (Alexandria, VA)  As part of its [...]

2707, 2017

UMDF Honors Volunteers With National Awards

July 27th, 2017|0 Comments

      FOR IMMEDIATE RELEASE July 27, 2017 Contact: Clifford Gorski Director of Communications 412.793.8077 cliff@umdf.org (Alexandria, VA)   At its annual international mitochondrial disease symposium, Mitochondrial Medicine 2017, the United Mitochondrial Disease Foundation [...]